TrialChinese medical journal2025

Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study.

Chao Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.